New Phase IV evidence for Menthacarin® published
2026-01-19
We are thrilled to announce that our latest study results on Menthacarin® have now been published in the scientific journal Wiener Medizinische Wochenschrift.
The study followed 126 patients with functional dyspepsia or irritable bowel syndrome–like symptoms over the course of an eight-week therapy with our peppermint oil–caraway oil combination Menthacarin® (2 × 1 capsule per day).
Key outcomes
• Abdominal symptoms like pain, cramps or bloating showed significant improvement
• Symptom days per week almost halved
• More days with normal stool consistency and fewer episodes of incomplete bowel movements
• Marked improvement in health‑related quality of life
• Excellent tolerability profile confirmed
These trial data underline the patient-relevant benefits of our evidence-based phytotherapeutic for disorders of gut–brain interaction.
🔗 Read the full paper: Treatment of disorders of gut–brain interaction with peppermint oil and caraway oil combination Menthacarin | Wiener Medizinische Wochenschrift